Development of vaccines at the time of COVID-19
© The Author(s) 2020. Published by Oxford University Press on behalf of FEMS..
In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Following the rapid and unpredicted spread of COVID-19 in the first seven months of 2020, the need to develop vaccines for pandemic viruses rapidly has been clearly established. Thus, this paper will concentrate on points that were highlighted by the recent COVID-19 pandemic and lessons learnt therefrom.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:1 |
|---|---|
| Enthalten in: |
microLife - 1(2020), 1 vom: 23. Juli, Seite uqaa003 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Almond, Jeffrey [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 24.05.2023 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1093/femsml/uqaa003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM32781425X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM32781425X | ||
| 003 | DE-627 | ||
| 005 | 20231225201621.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/femsml/uqaa003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1092.xml |
| 035 | |a (DE-627)NLM32781425X | ||
| 035 | |a (NLM)34235437 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Almond, Jeffrey |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Development of vaccines at the time of COVID-19 |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.05.2023 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © The Author(s) 2020. Published by Oxford University Press on behalf of FEMS. | ||
| 520 | |a In December 2019, a working group of the European Academy of Microbiology assembled to discuss various aspects of vaccines and vaccinations. The meeting was organised by Jörg Hacker and Eliora Z. Ron and took place in the offices of the Leopoldina (German National Academy of Sciences Leopoldina). Several important issues were addressed and a major part of the discussion focused on the need to develop new vaccines, especially to protect against pathogens that constitute a pandemic threat. Following the rapid and unpredicted spread of COVID-19 in the first seven months of 2020, the need to develop vaccines for pandemic viruses rapidly has been clearly established. Thus, this paper will concentrate on points that were highlighted by the recent COVID-19 pandemic and lessons learnt therefrom | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a pandemics | |
| 650 | 4 | |a pathogens | |
| 650 | 4 | |a vaccination | |
| 650 | 4 | |a vaccines | |
| 650 | 4 | |a vaccinology | |
| 700 | 1 | |a Hacker, Jörg |e verfasserin |4 aut | |
| 700 | 1 | |a Harwood, Colin |e verfasserin |4 aut | |
| 700 | 1 | |a Pizza, Mariagrazia |e verfasserin |4 aut | |
| 700 | 1 | |a Rappuoli, Rino |e verfasserin |4 aut | |
| 700 | 1 | |a Ron, Eliora Z |e verfasserin |4 aut | |
| 700 | 1 | |a Sansonetti, Philippe |e verfasserin |4 aut | |
| 700 | 1 | |a Vanderslott, Samantha |e verfasserin |4 aut | |
| 700 | 1 | |a Wieler, Lothar H |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t microLife |d 2020 |g 1(2020), 1 vom: 23. Juli, Seite uqaa003 |w (DE-627)NLM327814241 |x 2633-6693 |7 nnns |
| 773 | 1 | 8 | |g volume:1 |g year:2020 |g number:1 |g day:23 |g month:07 |g pages:uqaa003 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/femsml/uqaa003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 1 |j 2020 |e 1 |b 23 |c 07 |h uqaa003 | ||